Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.72 EUR | -1.06% | +3.33% | -17.70% |
Apr. 02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
Mar. 29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 53.48M 57.49M | Sales 2023 | 59.39M 63.85M | Capitalization | 51.4M 55.26M |
---|---|---|---|---|---|
Net income 2022 | 5M 5.38M | Net income 2023 | 5M 5.38M | EV / Sales 2022 | 0.69 x |
Net cash position 2022 | 5.64M 6.07M | Net Debt 2023 | 7.26M 7.81M | EV / Sales 2023 | 0.99 x |
P/E ratio 2022 |
7.2
x | P/E ratio 2023 |
9.2
x | Employees | 79 |
Yield 2022 |
4.69% | Yield 2023 |
-
| Free-Float | 12.01% |
1 day | -1.06% | ||
1 week | +3.33% | ||
Current month | -1.59% | ||
1 month | +1.64% | ||
3 months | -17.70% | ||
6 months | -18.78% | ||
Current year | -17.70% |
Managers | Title | Age | Since |
---|---|---|---|
Antonio Scala
CEO | Chief Executive Officer | 39 | 13-12-31 |
Giuseppe Somma
IRC | Investor Relations Contact | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Mazzarese
BRD | Director/Board Member | 45 | 18-12-31 |
Lucio Fusaro
BRD | Director/Board Member | 68 | 21-12-31 |
Umberto di Maio
FOU | Founder | 51 | 14-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 3.72 | -1.06% | 750 |
24-05-06 | 3.76 | +2.17% | 4,250 |
24-05-03 | 3.68 | -5.15% | 49,750 |
24-05-02 | 3.88 | +2.65% | 25,500 |
24-04-30 | 3.78 | +5.00% | 5,250 |
Real-time Borsa Italiana, May 07, 2024 at 11:44 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.70% | 46.03M | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |
- Stock Market
- Equities
- SHE Stock